✦ LIBER ✦

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

✍ Scribed by Narikazu Boku; Seiichiro Yamamoto; Haruhiko Fukuda; Kuniaki Shirao; Toshihiko Doi; Akira Sawaki; Wasaburo Koizumi; Hiroshi Saito; Kensei Yamaguchi; Hiroya Takiuchi; Junichiro Nasu; Atsushi Ohtsu

Book ID: 117785134
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 10
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(09)70259-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus S-1 (IRIS) versus fluoro

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)

✍ Kei Muro; Narikazu Boku; Yasuhiro Shimada; Akihito Tsuji; Shinichi Sameshima; Hi 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 310 KB

Results of a randomised phase II study o

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with α-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

✍ D.J.T Wagener; J.A Wils; T.C Kok; A Planting; M.L Couvreur; B Baron 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 122 KB

6578 A randomized phase II study of irin

6578 A randomized phase II study of irinotecan monotherapy versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancer

✍ Park, Y.; Sym, S.; Park, J.; Cho, E.; Shin, D.; Lee, J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Phase I study of irinotecan and S-1 comb

Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer

✍ Yasuhide Yamada; Hisateru Yasui; Ayumu Goto; Tatsuhiro Arai; Takashi Ura; Tetsuy 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

A phase III randomized study of 5-fluoro

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

✍ Noe Kyeong Kim; Young Suk Park; Dae Seog Heo; Cheolwon Suh; Si Young Kim; Keun C 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB